Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Symbol
EKSO
Shares outstanding
29,997,317 shares
Disclosed Ownership
2,996,732 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:27:05 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 10% ownership in EKSO BIONICS HOLDINGS, INC. Common Stock, $0.001 par value per share (EKSO) on 31 Mar 2025."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for EKSO BIONICS HOLDINGS, INC. Common Stock, $0.001 par value per share (EKSO).
  • Disclosed ownership: 10%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 15 May 2025, 15:27.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 10% 2,996,732 0 2,996,732 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 10% 2,996,732 0 2,996,732 /s/ Steven Boyd Steven Boyd